6:13 PM
 | 
Sep 10, 2012
 |  BC Extra  |  Company News

Annovation debuts to develop anesthetics

Annovation Biopharma Inc. debuted to develop anesthetics with $8 million in a series A round from Atlas Venture; Partners Innovation Fund; and The Medicines Co. (NASDAQ:MDCO). Annovation is working on small molecule GABA-A receptor agonists that are...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >